1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Pancreatic Neoplasms in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (29.41) | 29.6817 |
| 2010's | 10 (58.82) | 24.3611 |
| 2020's | 2 (11.76) | 2.80 |
| Authors | Studies |
|---|---|
| Cox, T; Leeuwenkamp, O; O'Connell, M; Palimaka, S; Reed, N | 1 |
| Djaker, N; Khan, M; Li, X; Liu, H; Marsich, E; Sacco, P; Spadavecchia, J | 1 |
| Balasse, L; Bouhlel, A; Ding, L; Fernandez, S; Garrigue, P; Giorgio, S; Guillet, B; Laurini, E; Louis, B; Lyu, Z; Marson, D; Mas, E; Peng, L; Pricl, S; Tintaru, A | 1 |
| Aprile, C; Facoetti, A; Frangipane, V; Hodolič, M; Lodola, L; Marenco, M; Persico, MG | 1 |
| Altmann, A; Babich, J; Haberkorn, U; Herold-Mende, C; Jäger, D; Lindner, T; Marmé, F; Mier, W; Müller, M; Rathke, H; Sauter, M | 1 |
| Andreae, F; Decristoforo, C; Helbok, A; Ocak, M; Radolf, T; Rangger, C; Virgolini, IJ; Von Guggenberg, E | 1 |
| Baker, AF; Douglas, MJ; Howison, CM; Maine, EA; Pagel, MD; Pineda, CT; Sheth, VR; Yoo, B | 1 |
| Conti, PS; Gill, PS; Krasnoperov, V; Li, D; Li, Z; Liu, R; Liu, S; Shan, H; Wang, H; Yuan, H | 1 |
| Abdel-Atti, D; Houghton, JL; Lewis, JS; Sawada, R; Scholz, WW; Zeglis, BM | 1 |
| Antwi, K; Banks, M; Campbell, F; Christ, E; Cuthbertson, DJ; Khoo, B; Raraty, M; Wild, D | 1 |
| Autio, A; Jalkanen, S; Luoto, P; Roivainen, A; Salomäki, S; Ujula, T | 1 |
| Antoch, G; Binse, I; Bockisch, A; Boy, C; Brandau, W; Lahner, H; Petersenn, S; Poeppel, TD; Schott, M | 1 |
| de Jong, M; de Visser, M; Erion, JL; Janssen, PJ; Krenning, EP; Reubi, JC; Schmidt, MA; Srinivasan, A; Waser, B | 1 |
| Chen, J; de Jong, M; Ginj, M; Maecke, HR; Reubi, JC; Schmitt, JS; Schulz, S; Waser, B | 1 |
| Antunes, P; Baum, RP; Ginj, M; Maecke, H; Reubi, JC; Waser, B; Zhang, H | 1 |
| Decaudin, D; Ellison, D; Finucane, C; Kadouche, J; Mather, SJ; Sabbah, EN | 1 |
| Beglinger, C; Christe, M; Eberle, AN; Eisenwiener, K; Froidevaux, S; Heppeler, A; Mäcke, HR; Schmitt, JS; Sumanovski, L | 1 |
17 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Pancreatic Neoplasms
| Article | Year |
|---|---|
Real-world comparison of healthcare resource utilization and costs of [
Topics: Cohort Studies; Heterocyclic Compounds, 1-Ring; Hospitals; Humans; Intestinal Neoplasms; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Patient Acceptance of Health Care; Somatostatin; Stomach Neoplasms | 2022 |
DOTAREM (DOTA)-Gold-Nanoparticles: Design, Spectroscopic Evaluation to Build Hybrid Contrast Agents to Applications in Nanomedecine.
Topics: Animals; Chitosan; Cholangiocarcinoma; Contrast Media; Gold; Heterocyclic Compounds, 1-Ring; Humans; Lactose; Meglumine; Metal Nanoparticles; Mice; Organometallic Compounds; Pancreatic Neoplasms; Polymers | 2022 |
A self-assembling amphiphilic dendrimer nanotracer for SPECT imaging.
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Chelating Agents; Dendrimers; Heterocyclic Compounds, 1-Ring; Humans; Indium; Indium Radioisotopes; Mice; Micelles; Nanostructures; Pancreatic Neoplasms; Radioisotopes; Surface-Active Agents; Tomography, Emission-Computed, Single-Photon | 2019 |
Evidence of
Topics: Adenocarcinoma; Animals; Cell Line, Tumor; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Neurotensin; Pancreatic Neoplasms; Peptide Fragments; Receptors, Neurotensin | 2018 |
Preclinical evaluation of peptide-based radiotracers for integrin αvβ6-positive pancreatic carcinoma.
Topics: Amino Acid Sequence; Animals; Antigens, Neoplasm; Cell Line, Tumor; Heterocyclic Compounds, 1-Ring; Humans; Integrins; Mice; Mice, Inbred BALB C; Oligopeptides; Pancreatic Neoplasms; Radioactive Tracers; Tissue Distribution | 2019 |
Design and evaluation of novel radiolabelled VIP derivatives for tumour targeting.
Topics: Animals; Binding, Competitive; Carcinoma, Pancreatic Ductal; Cells, Cultured; CHO Cells; Cricetinae; Drug Design; Female; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Peptide Fragments; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Vasoactive Intestinal Peptide; Tissue Distribution; Vasoactive Intestinal Peptide | 2013 |
Detection of in vivo enzyme activity with CatalyCEST MRI.
Topics: Animals; Catalysis; Cell Line, Tumor; Enzyme Activation; Feasibility Studies; Heterocyclic Compounds, 1-Ring; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mice; Molecular Imaging; Pancreatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Urokinase-Type Plasminogen Activator | 2014 |
Small-Animal PET Imaging of Pancreatic Cancer Xenografts Using a 64Cu-Labeled Monoclonal Antibody, MAb159.
Topics: Animals; Antibodies, Monoclonal, Humanized; Cell Line, Tumor; Copper Radioisotopes; Endoplasmic Reticulum Chaperone BiP; Female; Heat-Shock Proteins; Heterocyclic Compounds, 1-Ring; Humans; Immunoglobulin G; Mice; Mice, Nude; Microscopy, Fluorescence; Neoplasm Transplantation; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2015 |
Pretargeted Immuno-PET of Pancreatic Cancer: Overcoming Circulating Antigen and Internalized Antibody to Reduce Radiation Doses.
Topics: Animals; Antibodies, Neoplasm; Antigens, Neoplasm; Cell Line, Tumor; Copper Radioisotopes; Deferoxamine; Heterocyclic Compounds, 1-Ring; Humans; Mice; Neoplasm Transplantation; Pancreatic Neoplasms; Positron-Emission Tomography; Radiation Dosage; Radioisotopes; Radiopharmaceuticals; Tissue Distribution; Zirconium | 2016 |
Application of Ga(68) -DOTA-exendin-4 PET/CT to localize an occult insulinoma.
Topics: Exenatide; Female; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Hyperinsulinism; Hypoglycemia; Insulinoma; Middle Aged; Pancreas; Pancreatic Neoplasms; Pancreaticojejunostomy; Peptides; Positron Emission Tomography Computed Tomography; Treatment Outcome; Venoms | 2016 |
PET imaging of inflammation and adenocarcinoma xenografts using vascular adhesion protein 1 targeting peptide 68Ga-DOTAVAP-P1: comparison with 18F-FDG.
Topics: Adenocarcinoma; Amine Oxidase (Copper-Containing); Animals; Cell Adhesion Molecules; Cell Line, Tumor; Cell Transformation, Neoplastic; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds, 1-Ring; Humans; Inflammation; Male; Pancreatic Neoplasms; Peptides; Positron-Emission Tomography; Rats; Skin Diseases | 2010 |
Differential uptake of (68)Ga-DOTATOC and (68)Ga-DOTATATE in PET/CT of gastroenteropancreatic neuroendocrine tumors.
Topics: Aged; Aged, 80 and over; Female; Gallium Radioisotopes; Gastrointestinal Neoplasms; Heterocyclic Compounds, 1-Ring; Humans; Kidney; Male; Middle Aged; Multimodal Imaging; Neuroendocrine Tumors; Octreotide; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Stabilised 111In-labelled DTPA- and DOTA-conjugated neurotensin analogues for imaging and therapy of exocrine pancreatic cancer.
Topics: Animals; Drug Evaluation, Preclinical; Drug Stability; Heterocyclic Compounds, 1-Ring; Indium Radioisotopes; Isotope Labeling; Metabolic Clearance Rate; Mice; Mice, Nude; Neurotensin; Organ Specificity; Pancreas; Pancreatic Neoplasms; Pentetic Acid; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Neurotensin; Tissue Distribution; Whole-Body Counting | 2003 |
Design, synthesis, and biological evaluation of somatostatin-based radiopeptides.
Topics: Animals; Cell Line; Disease Models, Animal; Drug Design; Drug Screening Assays, Antitumor; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Male; Molecular Conformation; Neoplasm Transplantation; Octreotide; Pancreatic Neoplasms; Rats; Rats, Inbred Lew; Receptors, Somatostatin; Somatostatin; Stereoisomerism; Time Factors; Tissue Distribution; Tumor Cells, Cultured; Yttrium Radioisotopes | 2006 |
Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?
Topics: Animals; Cell Line, Tumor; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Isotope Labeling; Male; Metabolic Clearance Rate; Organ Specificity; Pancreatic Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Rats; Rats, Inbred Lew; Sensitivity and Specificity; Somatostatin; Tissue Distribution | 2007 |
In vitro and in vivo comparison of DTPA- and DOTA-conjugated antiferritin monoclonal antibody for imaging and therapy of pancreatic cancer.
Topics: Animals; Antibodies, Monoclonal; Cell Line, Tumor; Female; Ferritins; Heterocyclic Compounds, 1-Ring; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Mice, Nude; Organ Specificity; Pancreatic Neoplasms; Pentetic Acid; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Distribution | 2007 |
Neuroendocrine tumor targeting: study of novel gallium-labeled somatostatin radiopeptides in a rat pancreatic tumor model.
Topics: Animals; Antineoplastic Agents, Hormonal; Carcinoma, Neuroendocrine; Cells, Cultured; Female; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Kidney; Mice; Mice, Nude; Mice, SCID; Octreotide; Pancreatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tomography, Emission-Computed; Yttrium Radioisotopes | 2002 |